Sibutramine/Topiramate - Eurofarma
Alternative Names: Sibutramine/TopiramateLatest Information Update: 10 Feb 2022
At a glance
- Originator Eurofarma
- Class Cyclobutanes; Dioxolanes; Hexoses; Ketoses; Obesity therapies; Pyrans; Small molecules; Sulfonic acids
- Mechanism of Action GABA A receptor agonists; Serotonin uptake inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Obesity
Most Recent Events
- 01 Feb 2022 Preclinical trials in Obesity in Brazil (PO) (Eufarma website,
- 01 Feb 2022 Eurofarma plans a phase III trial for Obesity in Brazil (In adults) (NCT05209984)